Please assess the completion status of the following clinical trial:

Trial Title: CONCEPT: Crossover Efficacy Pain Trial in Motor Cortex Stimulation for Intractable Neuropathic Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* CPSP or TGN/facial pain refractory to other medical treatments~* Pain \> 1 year prior to baseline~* Pain intensity with an average daily VAS score \> 5 demonstrated by 12 ratings across 4 days~* Stable pain medication for \> 1 month prior to baseline~Exclusion Criteria:~* CPSP with important paresis/severe motor deficit in the area of pain~* TGN/facial pain with complete deafferentation pain~* Atypical facial pain, i.e. when objective evidence for neuropathic facial pain syndromes is lacking and when specific psychological and behavioral factors can be identified~* Pain associated with malignant neoplastic disease anywhere in the body or head~* History of epilepsy~* Presence of a deterioration of cognitive functions

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).